Survival with Systemic Sclerosis (Scleroderma)
Thomas A. Medsger, Alfonse T. Masi, Gerald P. Rodnan et al. · Annals of Internal Medicine · 1971
A life-table analysis of survivorship with scleroderma was done, using 223 patients diagnosed in Pittsburgh, Pennsylvania, and 86 patients in Memphis, Tennessee. The demographic and clinical characteristics of the two series were similar, thus allowing for both comparison of the two groups and analysis of the total 309 patients. A follow-up during 1970 was successful in 94% of all patients. No difference in survival was found between the two patient groups, the combined 7-year cumulative survivorship being 35%. Significantly decreased survival was found in older patients of both series after allowance was made for the natural increase of mortality with age. Males had significantly worse survival than females. Negroes had significantly worse survival than whites during the first year of follow-up of all patients. When no internal organ involvement was detected at entry to study, the negro prognosis was significantly worse throughout a 7-year follow-up period. Renal, cardiac, and pulmonary involvement were each independently correlated with decreased survival.
Cited by 321 works. doi:10.7326/0003-4819-75-3-369
Authors
References
- Evaluation of survival data and two new rank order statistics arising in its consideration.
- Epidemiology of Systemic Sclerosis (Scleroderma)
- Systemic Scleroderma
- SCLERODERMA (BASED ON A STUDY OF OVER 150 CASES)
- CLASSIFICATION AND PATHOGENESIS OF SCLERODERMA
- Carbohydrate Tolerance and Diabetes in a Total Community, Tecumseh, Michigan: 1. Effects of Age, Sex, and Test Conditions on One-hour Glucose Tolerance in Adults
- Vascular Disease in Progressive Systemic Sclerosis (Scleroderma)
- MULTIPLE TELANGIECTASIA, RAYNAUD'S PHENOMENON, SCLERODACTYLY, AND SUBCUTANIOUS CALCINOSIS: A SYNDROME MIMICKING HEREDITARY HEMORRHAGIC TELANGIECTASIA.
- Factors Affecting Survivorship in Polymyositis. A Life‐Table Study of 124 Patients
- Epidemiology of Fatal Systemic Sclerosis (Diffuse Scleroderma)